Learn More
Reports
Big Pharma Hikes Prices on Rare Disease Drugs - As Medicare Protections are Weakened
Patients For Affordable Drugs is released a new analysis finding that pharmaceutical companies raised prices on rare disease drugs just a few months after the passage of the ORPHAN Cures Act in the 2025 Reconciliation Package. Click here to download
Reports
Big Pharma Hikes Cancer Drugs for Americans
As Americans face growing anxiety about their ability to pay for health care in 2026, pharmaceutical corporations continue to raise prices on some of the most expensive drugs on the market: cancer treatments Click here to download
Reports
How Pharma Price Hikes and the EPIC Act Threaten Access to Lifesaving HIV Treatment
A new analysis from Patients For Affordable Drugs spotlights a troubling pattern: pharmaceutical companies are raising prices on HIV medications, while simultaneously lobbying Congress to pass the harmful EPIC Act. Click here to download
Reports
The Rampant Reach Of Pharma's Hidden Hand
How Industry-funded front groups undermine the fight to lower prescription drug prices. Click here to download
Reports
PhRMA’s False Claims About “Unintended Consequences” of the Inflation Reduction Act
Between September 2024 and mid-January 2025, PhRMA spent over $235,800 on 128 Meta ads to attack the Inflation Reduction Act’s drug price reforms. View full report here. Click here to download full report
Reports
New Reach of Pharma's Hidden Hand: Hiding In Plain Sight
Big Pharma isn’t just lobbying—it’s funding patient groups to fight reforms and protect its profits. Our latest report exposes how. Click here to download full report